Article | April 29, 2022

Disrupting The Traditional Approach To UAT

Source: IQVIA Technologies

By Kris Gustafson, Vice President, Global Head Patient Centered Technologies

GettyImages-1133603364-lab-equipment-microscope-beaker-test tube

Collecting accurate and timely data from patients plays a vital role throughout the developmental stages of a clinical trial – and the ability to quickly implement technologies to capture this data is essential. The sooner a trial is up and running, the sooner sponsors can recruit patients, collect data, and advance to market approval.

We are seeing a rapid, industry wide shift to direct-to-patient technologies, including electronic Clinical Outcomes Assessments (eCOAs), which can be rapidly implemented to capture patient reported outcomes (PROs), giving sponsors almost instant access to trends across the trial.

In clinical research, it is less than ideal to wait months for a software team from an eCOA provider to build and implement an electronic assessment for a trial. Especially when there is typically a lack of transparency throughout and you can’t preview the assessment until the end of those few months. User Acceptance Testing (UAT) is a step in the trial planning process, that is often extended when users see the finished product and realize it isn’t exactly what they envisioned.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader